Free Trial

Krystal Biotech (KRYS) SEC Filings & 10K Form

Krystal Biotech logo
$187.18 +4.16 (+2.27%)
Closing price 10/8/2025 04:00 PM Eastern
Extended Trading
$187.23 +0.05 (+0.03%)
As of 10/8/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Krystal Biotech SEC Filings

DateFilerForm TypeView
08/04/2025
6:04 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2025
6:09 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2025
8:03 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2025
3:45 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2025
5:41 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025
5:42 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2025
4:44 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2025
4:45 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2025
8:01 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2025
5:14 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
5:18 PM
Krystal Biotech (Issuer)
Sutherland Everett Rand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
5:23 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
4:59 PM
Krystal Biotech (Issuer)
Mazzacco Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
5:04 PM
Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
5:09 PM
Krystal Biotech (Issuer)
Mason Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
4:12 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
7:08 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
7:09 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
7:53 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
3:44 PM
Krystal Biotech (Filer)
Form ARS
04/03/2025
3:38 PM
Krystal Biotech (Filer)
Form DEF 14A
03/13/2025
5:04 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
5:06 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
5:58 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
6:00 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
6:01 PM
Krystal Biotech (Issuer)
ROMANO KATHRYN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
10:52 AM
Krystal Biotech (Subject)
ROMANO KATHRYN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
6:19 AM
Krystal Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2025
6:25 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
6:51 AM
Krystal Biotech (Subject)
STATE STREET CORP (Filed by)
Form SCHEDULE 13G
12/18/2024
7:39 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
5:27 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
5:28 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:22 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2024
7:30 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:00 PM
Krystal Biotech (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/04/2024
7:04 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
7:05 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/16/2024
11:28 AM
Krystal Biotech (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KRYS) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners